{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:51:36Z","timestamp":1767135096048,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd010008.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,4,23]],"date-time":"2017-04-23T00:00:00Z","timestamp":1492905600000}}],"reference-count":28,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010008.pub3","type":"journal-article","created":{"date-parts":[[2017,4,23]],"date-time":"2017-04-23T11:31:15Z","timestamp":1492947075000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Topiramate monotherapy for juvenile myoclonic epilepsy"],"prefix":"10.1002","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[{"name":"Xuanwu Hospital, Capital Medical University; Department of Neurology; Changchun Street 45 Beijing China 100053"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Ning","family":"Wang","sequence":"additional","affiliation":[{"name":"Chinese PLA General Hospital; Department of Geriatric Neurology; Fuxing Road 28 Haidian District Beijing China 100853"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Xuanwu Hospital, Capital Medical University; Department of Neurology; Changchun Street 45 Beijing China 100053"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,4,23]]},"reference":[{"key":"10.1002\/14651858.CD010008.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/archneur.62.11.1705","article-title":"Topiramate in patients with juvenile myoclonic epilepsy","volume":"62","author":"Biton","year":"2005","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.yebeh.2007.03.003","article-title":"Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison","volume":"10","author":"Levisohn","year":"2007","journal-title":"Epilepsy & Behavior"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jocn.2012.10.020","article-title":"A randomized open-label observational study to compare the efficacy and tolerability between topiramate and valproate in juvenile myoclonic epilepsy","volume":"20","author":"Park","year":"2013","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1590\/S0004-282X2005000500001","article-title":"Topiramate for the treatment of juvenile myoclonic epilepsy","volume":"63","author":"Sousa Pda","year":"2005","journal-title":"Arquivos de Neuro-psiquiatria"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1590\/S0004-282X2007000700036","article-title":"Juvenile myoclonic epilepsy","volume":"65","author":"Alfradique","year":"2007","journal-title":"Arquivos de Neuro-psiquiatria"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.52.7.1330","article-title":"A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures","volume":"52","author":"Biton","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1059-1311(00)90530-2","article-title":"Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate","volume":"10","author":"Calleja","year":"2001","journal-title":"Seizure"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0008|cit8","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD010008.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0010|cit10","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A (editors) Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October 2013 gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1600-0404.2002.02071.x","article-title":"Low-dose topiramate in adults with treatment-resistant partial-onset seizures","volume":"106","author":"Guberman","year":"2002","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0006-8993(98)00116-4","article-title":"Suppression by topiramate of epileptiform burst discharges in hippocampal CA3 neurons of spontaneously epileptic rat in vitro","volume":"789","author":"Hanaya","year":"1998","journal-title":"Brain Research"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0014|cit14","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1528-1167.2005.00309.x","article-title":"Epidemiology of idiopathic generalized epilepsies","volume":"46 (Suppl 9)","author":"Jallon","year":"2005","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-0404.1985.tb00900.x","article-title":"Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy)","volume":"72","author":"Janz","year":"1985","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0018|cit18","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD010008.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1528-1167.2009.02230.x","article-title":"The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?","volume":"50","author":"Montouris","year":"2009","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1528-1157.1991.tb04708.x","article-title":"Juvenile myoclonic epilepsy: factors of error involved in the diagnosis and treatment","volume":"32","author":"Panayiotopoulos","year":"1991","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0021|cit21","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/WNL.52.9.1882","article-title":"A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0023|cit23","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.seizure.2007.07.001","article-title":"Levetiracetam monotherapy in juvenile myoclonic epilepsy","volume":"17","author":"Sharpe","year":"2008","journal-title":"Seizure"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/j.1528-1157.2000.tb02165.x","article-title":"Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism","volume":"41 Suppl 1","author":"White","year":"2000","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD010008.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3940(97)00543-0","article-title":"Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells","volume":"231","author":"Zona","year":"1997","journal-title":"Neuroscience Letters"},{"issue":"8","key":"10.1002\/14651858.CD010008.pub3-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010008","article-title":"Topiramate monotherapy for juvenile myoclonic epilepsy","author":"Liu","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD010008.pub3-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010008.pub2","article-title":"Topiramate monotherapy for juvenile myoclonic epilepsy","author":"Liu","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd010008.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010008.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:39:18Z","timestamp":1628534358000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD010008.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,23]]},"references-count":28,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010008.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,23]]}}}